Align Technology Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Los beneficios de Align Technology han disminuido a una tasa media anual de -17%, mientras que en la industria Medical Equipment los beneficios disminuyeron en un 5.9% anualmente. Los ingresos han ido creciendo a una tasa media de 13.7% al año. La rentabilidad financiera de Align Technology es de 12.3%, y sus márgenes netos son de 11.8%.

Información clave

-17.0%

Tasa de crecimiento de los beneficios

-16.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	-9.5%
Tasa de crecimiento de los ingresos	13.7%
Rentabilidad financiera	12.3%
Margen neto	11.8%
Próxima actualización de resultados	24 Jul 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Align Technology. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

LSE:0HCK Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	3,917	462	1,716	351
31 Dec 23	3,862	445	1,703	347
30 Sep 23	3,807	363	1,711	348
30 Jun 23	3,737	314	1,701	336
31 Mar 23	3,705	315	1,675	321
31 Dec 22	3,735	362	1,674	305
30 Sep 22	3,864	511	1,716	294
30 Jun 22	3,990	619	1,745	283
31 Mar 22	4,031	706	1,751	268
31 Dec 21	3,953	772	1,709	250
30 Sep 21	3,756	740	1,606	227
30 Jun 21	3,474	698	1,490	206
31 Mar 21	2,816	458	1,315	188
31 Dec 20	2,472	1,776	1,201	175
30 Sep 20	2,287	1,738	1,132	168
30 Jun 20	2,160	1,701	1,097	163
31 Mar 20	2,409	1,889	1,108	161
31 Dec 19	2,407	443	1,072	157
30 Sep 19	2,291	419	1,019	152
30 Jun 19	2,189	417	956	145
31 Mar 19	2,079	376	900	137
31 Dec 18	1,966	400	852	129
30 Sep 18	1,854	313	808	119
30 Jun 18	1,734	295	763	111
31 Mar 18	1,600	258	714	104
31 Dec 17	1,473	231	666	98
30 Sep 17	1,345	269	614	93
30 Jun 17	1,239	238	571	89
31 Mar 17	1,151	219	530	83
31 Dec 16	1,080	190	491	76
30 Sep 16	1,017	191	460	68
30 Jun 16	946	167	435	65
31 Mar 16	886	148	414	62
31 Dec 15	845	144	390	61
30 Sep 15	814	135	377	61
30 Jun 15	796	145	355	56
31 Mar 15	779	150	338	53
31 Dec 14	762	146	332	53
30 Sep 14	740	149	319	50
30 Jun 14	714	145	311	49
31 Mar 14	684	139	302	46
31 Dec 13	660	64	293	44
30 Sep 13	619	31	286	45
30 Jun 13	591	-3	275	44

Ingresos de calidad: 0HCK tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (11.8%) de 0HCK son superiores a los del año pasado (8.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 0HCK han disminuido en un 17% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de 0HCK en el último año (46.7%) supera su media de 5 años (-17% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de 0HCK en el último año (46.7%) superó al de la industria Medical Equipment 17.9%.

Align Technology Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: EPS: US$1.40 (vs US$1.14 in 1Q 2023)

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Third quarter 2023 earnings released: EPS: US$1.59 (vs US$0.93 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$1.46 (vs US$1.44 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$1.14 (vs US$1.71 in 1Q 2022)

Recent updates

Align Technology, Inc. Revises Earnings Guidance for the Fiscal Full Year 2024

First quarter 2024 earnings released: EPS: US$1.40 (vs US$1.14 in 1Q 2023)

Align Technology, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Align Technology, Inc., Annual General Meeting, May 22, 2024

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Independent Director recently sold US$7.7m worth of stock

U.S. District Court for Northern District of California Grants Summary Judgment in Favor of Align Technology, Inc. in Two Antitrust Class Action Lawsuits

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Align Technology, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 21%

Align Technology, Inc. Receives US FDA 510(K) Clearance for the Invisalign Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Health Canada Issues Medical Device License to Align Technology for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion

Align Technology, Inc. Announces Board Appointments

President recently bought US$1m worth of stock

President recently bought US$1m worth of stock

Investor sentiment deteriorates as stock falls 31%

New minor risk - Share price stability

Now 32% undervalued after recent price drop

Align Technology, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: EPS: US$1.59 (vs US$0.93 in 3Q 2022)

Align Technology, Inc. (NasdaqGS:ALGN) entered into a definitive agreement to acquire additional unknown stake in Cubicure GmbH for €79 million.

Superior Court of California, County of Santa Clara, Confirms $63 Million Arbitration Award in Favor of Align Technology and Denies SmileDirectClub’s Motion to Vacate

New minor risk - Share price stability

Align Technology, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023

Second quarter 2023 earnings released: EPS: US$1.46 (vs US$1.44 in 2Q 2022)

Align Technology, Inc.(NasdaqGS:ALGN) dropped from Russell 1000 Value Index

Independent Director recently bought US$2.0m worth of stock

First quarter 2023 earnings released: EPS: US$1.14 (vs US$1.71 in 1Q 2022)

President recently bought US$1m worth of stock

Align Technology, Inc. Announces Executive Changes in iTero Scanner and Services

Full year 2022 earnings released: EPS: US$4.62 (vs US$9.78 in FY 2021)

Investor sentiment improves as stock rises 38%

Align Technology, Inc. (NasdaqGS:ALGN) announces an Equity Buyback for $1,000 million worth of its shares.

Align Technology, Inc. to Report Q4, 2022 Results on Feb 01, 2023

Now 20% undervalued after recent price drop

DentalMonitoring SAS Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology, Inc

Insufficient new directors

President recently bought US$2.0m worth of stock

Third quarter 2022 earnings released: EPS: US$0.93 (vs US$2.29 in 3Q 2021)

Align Technology, Inc. Introduces Latest Itero-Exocad Connector™ Software Release That Enables Advanced Visualization for Doctors and Labs, with Seamless Integration of Itero™ Intraoral Camera and Niri Images Within Exocad™ Software

Align Technology, Inc. Introduces Invisalign Virtual Care AI

Second quarter 2022 earnings released: EPS: US$1.44 (vs US$2.53 in 2Q 2021)

Insufficient new directors

Align Technology, Inc. Introduces Invisalign Outcome Simulator Pro

First quarter 2022 earnings released: EPS: US$1.71 (vs US$2.54 in 1Q 2021)

Now 37% undervalued after recent price drop

Insufficient new directors

Now 23% undervalued after recent price drop

Align Technology, Inc., Annual General Meeting, May 18, 2022

Investor sentiment improved over the past week

Now 23% undervalued after recent price drop

Align Technology, Inc. Announces Settlement of Outstanding Litigation with 3Shape A/S

Now 22% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Align Technology, Inc. Announces Invisalign System Innovations for the Align Digital Platform

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

CFO & Senior VP of Global Finance recently sold US$2.1m worth of stock

Third quarter 2021 earnings released: EPS US$2.29 (vs US$1.77 in 3Q 2020)

Independent Director recently sold US$3.6m worth of stock

Insider recently sold US$6.5m worth of stock

Second quarter 2021 earnings released: EPS US$2.53 (vs US$0.52 loss in 2Q 2020)

Align Technology, Inc.(NasdaqGS:ALGN) dropped from Russell Midcap Growth Index

Align Technology Introduces the Limited-Edition Charli D’Amelio x Invisalign® Aligner Case

AligAlign Technology Releases iTero Workflow 2.0 Software and Previews New iTero Element 5D Imaging System Auto-Upload Functionality

CFO & Senior VP of Global Finance recently sold US$4.1m worth of stock

Align Technology, Inc. (NasdaqGS:ALGN) announces an Equity Buyback for $1,000 million worth of its shares.

Independent Chairman recently sold US$3.0m worth of stock

Desglose de ingresos y gastos
Beta